[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.158.163. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,502
Citations 0
Evidence to Practice
October 2016

CardioMEMS HF for the Management of Heart Failure—Effectiveness and Value

Author Affiliations
  • 1Institute for Clinical and Economic Review, Boston, Massachusetts
  • 2Center for Health Policy/Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University, Palo Alto, California
  • 3Veterans Affairs Palo Alto Health Care System, Palo Alto, California
JAMA Intern Med. 2016;176(10):1551-1552. doi:10.1001/jamainternmed.2016.5467

The Institute for Clinical and Economic Review developed an evidence report, including a systematic literature review and economic evaluation, to support a meeting of the California Technology Assessment Forum on October 29, 2015, on the CardioMEMS HF system (St Jude Medical, Inc) for heart failure (HF).1

The 5-year mortality rate for patients with chronic HF is similar to that for many cancers, and the disease is characterized by high rates of hospitalization.2 Heart failure currently affects more than 6 million Americans and causes 1 million hospitalizations annually.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×